Abeona Therapeutics Inc. Common Stock
ABEOAbeona Therapeutics Inc. is a clinical-stage biotech company focused on developing gene and cell therapies for rare genetic diseases. The company aims to address serious and life-threatening conditions by utilizing innovative approaches to improve patient outcomes in areas such as immune disorders, neurological diseases, and genetic disorders.
Company News
Abeona Therapeutics saw a significant stock surge of over 25% after reporting strong Q3 earnings and positive updates on Zevaskyn, its gene therapy treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB), with major insurers now covering the treatment.
The global cancer gene therapy market is projected to grow from $4.52 billion in 2024 to $13.58 billion by 2030, driven by rising cancer incidences, advancements in personalized medicine, and innovative gene therapy technologies like CRISPR and CAR-T solutions.
The Dow Jones index closed higher by around 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable in...
3 Penny Stocks To Watch Now The post 3 Penny Stocks To Watch Before Next Week; Time To Buy? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
